International Biotechnology (IBT) Competitors GBX 684 +2.00 (+0.29%) (As of 12:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades IBT vs. JPE, FSV, IEM, RICA, SAIN, BBGI, JEO, APEO, OCI, and MUTShould you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include JPMorgan Elect plc - Managed Growth (JPE), Fidelity Investment Trust - Fidelity Special Values (FSV), Impax Environmental Markets (IEM), Ruffer Investment (RICA), Scottish American Investment (SAIN), BBGI Global Infrastructure (BBGI), European Opportunities Trust (JEO), abrdn Private Equity Opportunities (APEO), Oakley Capital Investments (OCI), and Murray Income Trust (MUT). These companies are all part of the "asset management" industry. International Biotechnology vs. JPMorgan Elect plc - Managed Growth Fidelity Investment Trust - Fidelity Special Values Impax Environmental Markets Ruffer Investment Scottish American Investment BBGI Global Infrastructure European Opportunities Trust abrdn Private Equity Opportunities Oakley Capital Investments Murray Income Trust International Biotechnology (LON:IBT) and JPMorgan Elect plc - Managed Growth (LON:JPE) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment. Which has stronger earnings & valuation, IBT or JPE? International Biotechnology has higher earnings, but lower revenue than JPMorgan Elect plc - Managed Growth. JPMorgan Elect plc - Managed Growth is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInternational Biotechnology£24.14M10.47£18.19M£0.481,425.00JPMorgan Elect plc - Managed Growth£104.78M9.57N/A£0.751,250.00 Do analysts rate IBT or JPE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score International Biotechnology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AJPMorgan Elect plc - Managed Growth 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is IBT or JPE more profitable? International Biotechnology has a net margin of 75.33% compared to JPMorgan Elect plc - Managed Growth's net margin of 0.00%. International Biotechnology's return on equity of 6.25% beat JPMorgan Elect plc - Managed Growth's return on equity.Company Net Margins Return on Equity Return on Assets International Biotechnology75.33% 6.25% 3.57% JPMorgan Elect plc - Managed Growth N/A N/A N/A Does the MarketBeat Community believe in IBT or JPE? International Biotechnology received 67 more outperform votes than JPMorgan Elect plc - Managed Growth when rated by MarketBeat users. Likewise, 77.71% of users gave International Biotechnology an outperform vote while only 62.73% of users gave JPMorgan Elect plc - Managed Growth an outperform vote. CompanyUnderperformOutperformInternational BiotechnologyOutperform Votes13677.71% Underperform Votes3922.29% JPMorgan Elect plc - Managed GrowthOutperform Votes6962.73% Underperform Votes4137.27% Do institutionals and insiders hold more shares of IBT or JPE? 45.2% of International Biotechnology shares are owned by institutional investors. 4.2% of International Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer IBT or JPE? In the previous week, International Biotechnology had 1 more articles in the media than JPMorgan Elect plc - Managed Growth. MarketBeat recorded 1 mentions for International Biotechnology and 0 mentions for JPMorgan Elect plc - Managed Growth. International Biotechnology's average media sentiment score of 0.75 beat JPMorgan Elect plc - Managed Growth's score of 0.00 indicating that International Biotechnology is being referred to more favorably in the media. Company Overall Sentiment International Biotechnology Positive JPMorgan Elect plc - Managed Growth Neutral Is IBT or JPE a better dividend stock? International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 4.2%. JPMorgan Elect plc - Managed Growth pays an annual dividend of GBX 0.17 per share and has a dividend yield of 0.0%. International Biotechnology pays out 6,041.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. JPMorgan Elect plc - Managed Growth pays out 22.9% of its earnings in the form of a dividend. SummaryInternational Biotechnology beats JPMorgan Elect plc - Managed Growth on 12 of the 15 factors compared between the two stocks. Ad Porter & CompanyRigged election? Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night Get International Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBT vs. The Competition Export to ExcelMetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£252.81M£772.64M£3.15B£1.40BDividend Yield4.39%13.41%4.61%11.78%P/E Ratio1,425.00748.47431.221,561.46Price / Sales10.4713,623.012,979.53209,782.91Price / Cash155.7479.1148.0032.90Price / Book0.911.692.272.85Net Income£18.19M£57.11M£394.92M£153.09M7 Day Performance-0.03%0.03%6.24%4.74%1 Month Performance1.48%-0.85%0.02%3.34%1 Year Performance18.54%11.99%16.32%106.65% International Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTInternational BiotechnologyN/AGBX 684+0.3%N/A+18.4%£252.81M£24.14M1,425.00N/AHigh Trading VolumeJPEJPMorgan Elect plc - Managed GrowthN/AGBX 937.50flatN/AN/A£1.00B£104.78M1,250.00N/AFSVFidelity Investment Trust - Fidelity Special ValuesN/AGBX 307.50-1.4%N/AN/A£996.61M£11.88M-30,750.0025,000IEMImpax Environmental MarketsN/AGBX 391.23-0.8%N/A+9.4%£982.29M£1.57M-9,780.68N/AHigh Trading VolumeRICARuffer InvestmentN/AGBX 273.86-0.2%N/AN/A£950.39M£19.58M9,128.50N/ASAINScottish American InvestmentN/AGBX 506-0.8%N/A+6.2%£902.30M£103.33M1,012.00N/ABBGIBBGI Global InfrastructureN/AGBX 126-1.7%N/A-8.1%£900.56M£68.47M1,575.001,160High Trading VolumeJEOEuropean Opportunities TrustN/AGBX 843-2.4%N/AN/A£886.70M£-62,326,000.00-12.93N/APositive NewsAPEOabrdn Private Equity OpportunitiesN/AGBX 574-1.0%N/AN/A£880.29M£80.21M1,435.00N/AOCIOakley Capital InvestmentsN/AGBX 494.80-0.6%N/A+12.5%£872.93M£99.09M989.60N/AMUTMurray Income TrustN/AGBX 829-1.2%N/A+3.6%£860.67M£88.65M1,151.39147,000Dividend CutNews Coverage Related Companies and Tools Related Companies JPMorgan Elect plc - Managed Growth Competitors Fidelity Investment Trust - Fidelity Special Values Competitors Impax Environmental Markets Competitors Ruffer Investment Competitors Scottish American Investment Competitors BBGI Global Infrastructure Competitors European Opportunities Trust Competitors abrdn Private Equity Opportunities Competitors Oakley Capital Investments Competitors Murray Income Trust Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:IBT) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
